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ABSTRACT:  Weanling Sprague-Dawley rats were fed on a choline-deficient diet with hydrogenated veg-
etable oil and corn oil as lipids develop acute renal failure. Pathogenesis of the latter is controversial and an
ischemic mechanism has been proposed. Arachidonic acid derivatives are involved in the regulation of vascu-
lar tonus. Vasospasm could be due to an increase in tromboxane A2-mediated vasoconstriction or to a de-
crease in prostacyclin-induced vasodilatation. Enzymes involved in the synthesis of both compounds are
tromboxane A2- and prostacyclin-synthase respectively. The aim of this study was to identify the variable
number tandem repeats (VNTR) in the promoter region of prostacyclin synthase gene and verify if there
exists a relationship between the occurrence of VNTR in those choline-deficient rats which die because of
acute renal failure and those which do not. We verified the presence of the VNTR in the prostacyclin synthase
rat gene, but we did not find any difference in the molecular weight of the alleles between experimental and
control rats. Renal reparation of the acute kidney injury due to choline deficiency in some rats is not related
with differences in VNTR in the promoter region of the prostacyclin synthase gene.
BIOCELL
2010, 34(2): 65-70
ISSN 0327 - 9545
PRINTED IN ARGENTINA
Introduction
Choline is crucial for sustaining life. It modulates
basic signaling processes within the cell, it is a struc-
tural element in membranes and it is vital during criti-
cal periods in brain development. Since choline is widely
distributed in food, it has been difficult to identify a
human deficiency syndrome in healthy humans. How-
ever; vulnerable populations may become choline defi-
cient, including growing infants, pregnant and lactat-
ing woman (Zeisel and Blusztajn, 1994). Choline re-
quirements are modified by individual growth rate and
by complex interrelationships between choline and
methionine, folic acid, and vitamin B12. This quater-
nary amine is present in tissues predominantly as a con-
stituent of phosphatidylcholine and sphingomyelin.
It is known that female rats are more resistant to
ischemic acute kidney injury (acute renal failure) than
male rats (Takayama et al., 2007). We have observed
that weanling male rats fed on a choline-deficient diet
(with hydrogenated vegetable oil and corn oil as lipids)
develop acute kidney injury with morphological alter-
ations that vary from focal tubular necrosis to massive
cortical necrosis, but may either die as a consequence
of acute kidney failure (Montes de Oca et al., 1980) or
may resolve for unknown reasons.
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The pathogenesis of acute kidney injury due to
choline deficiency is controversial, and both an is-
chemic mechanism and primary tubular damage have
been proposed (Montes de Oca et al., 1980). The qual-
ity as well as the quantity of diet lipids modulates the
renal lesion due to choline deficiency (O’Neal et al.,
1961). Menhaden oil has a protective effect in this
experimental model. This oil is rich in eicosapentanoic
(20:5) and docosahexaenoic acids (22:6) and it may
influence renal fatty acid composition and arachidonic
acid metabolism which plays an important role in re-
nal physiopathology (Courrèges et al., 2002). This ef-
fect could be due to modifications in the vascular to-
nus as well as susceptibility of each particular rat.
Prostaglandins and tromboxans (=prostanoids) are
cyclic eicosanoids have potent vasodilatatory and
vasoconstrictory activities, respectively. Prostaglandin
H2 synthase catalyzes the conversion of arachidonic
acid to prostaglandin G2, and of the latter to prostag-
landin H2, and prostacyclin synthase catalyzes the re-
arrangement of prostaglandin H2 to prostacycline.
Prostacycline increases levels of intracellular cAMP
inducing vasodilatation and suppressing platelet ag-
gregation (Mayes, 1992) and may have direct
cytoprotective actions (Vane, 1983). Thromboxane A2
is also produced from prostaglandin H2, but induces
both vasoconstriction and platelet aggregation (Mayes,
1992). Hence, when the action of prostacyclin synthase
is hindered, diseases such as hypertension, thrombo-
sis and embolism may result, and thus the prostacyclin
synthase gene may represent a disease susceptibility
gene. Prostacyclin synthase is widely distributed in the
organism. It is a membrane-associated P450-like en-
zyme with a molecular mass of 52 kDa. Like many
others P450 molecules, prostacyclin synthase binds not
only with its substrate, prostaglandin H2, but also with
heme molecules (Nelson et al., 1996). Miyata et al.
(1994) reported the DNA copy sequence of human
prostacyclin synthase, and Nakayama et al. (1996)
clarified the genomic structure. The genetic locus of
prostacyclin synthase is 20q13.11-13 (NCBI Gene
ID:5740). A single copy gene contains 10 exons and is
approximately 70 kbp in length. The size of the exons
ranges from 74 bp (ATG-exon 1) to 182 bp (exons 6
and 8) and the size of the introns ranges from approxi-
mately 1 kb (intron 7) to 19 kb (intron 1). In the core
promoter region, 9 bp repeated sequences exist just
upstream of the initiation codon, and transcription fac-
tors bind in tandem, as variable number tandem re-
peats (VNTR). A VNTR is a short nucleotide sequence
ranging from 14 to 100 nucleotides in length. It is or-
ganized into clusters of tandem repeats, usually re-
peated in the range of between 4 and 40 times per oc-
currence. Clusters of such repeats are scattered on
many chromosomes. Each variant is an allele and they
are inherited codominantly. The number of times that
a sequence is repeated varies between different indi-
viduals and between maternal and paternal loci of an
individual. The likelihood of two individuals having
the same band pattern is extremely improbable. The
number of repeats will determine the length of the frag-
ment of DNA. The repeat sequence itself can be used
as a probe, or if the repeat is not long enough, a se-
quence from the upstream or downstream side can be
used. There are two principal families of VNTR: mini-
and microsatellites. The former are sequences of 11-
16 bp repeated 1000 times. They are important because
they are highly repetitive and dispersed into the ge-
nome. The other members of the VNTR family are the
microsatellites or short tandem repeats. They are rep-
resented by short sequences of 100-200 bp given by
the repetition of 1-6 bp sequences (Claros et al., 2004).
Expression of prostacyclin synthase is high in
heart, lung, smooth muscle, kidney and ovary, moder-
ate in brain, pancreas and prostate, and low in placenta,
spleen and leukocytes (Jeremy et al., 1985). A previ-
ous study, using prostacyclin synthase knockout mice,
found that the complete loss of prostacyclin synthase
(-/- type) caused hypertension, fibrosis and vascular
injury in atrophic kidneys, and increased levels of
blood urea, nitrogen and creatinine (Yokoyama et al.,
2002). The locus of Rattus norvegicus prostacyclin
synthase is 3q42 (NCBI Gene ID:25527). Genetic
mutations that bring about changes in amino acid resi-
dues could therefore affect enzymatic activity. Poole
et al. (2007) suggested that individuals with fewer
prostacyclin synthase repeats would be at increased
risk of colorectal polyps. Small number repeats allele
was found more frequently associated to cerebral inf-
arction and transcriptional activity increases with in-
creasing numbers of repeats (Nakayama et al., 2000;
Nakayama, 2005). On the other hand, this polymor-
phism did not seem to be associated with the develop-
ment of chronic thromboembolic pulmonary hyperten-
sion and essential hypertension (Amano et al., 2004;
Nakayama et al., 2001).
The aim of this study was to identify the VNTR in
the promoter region of prostacyclin synthase gene and
verify if there exists a relationship between the VNTR
and those rats fed on the choline deficient diet which
die as a consequence of acute renal failure and those
which do not.
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Material and Methods
Animals
This study was performed on ten buffered forma-
lin fixed, paraffin embedded renal tissue samples from
a previous study (experiment 1, group 1; Courrèges et
al., 2002). They were from Sprague-Dawley weanling
male rats (21-23 days) which were fed ad libitum on a
choline-deficient diet with hydrogenated vegetable oil
and corn oil as lipids (Table 1). Some rats were kept on
this diet until they died from acute renal failure (group
1, n=6) or were sacrificed on day 21 of choline-defi-
cient diet feeding (group 2, n =4). Both body and kid-
neys weights were recorded for each animal (Courrèges
et al., 2002). Tissue samples were fixed in buffered for-
malin and embedded in paraffin.
terations, which were classified according to Monserrat
et al. (1981) into (grade 0), no necrosis; (grades 1 to
4), tubular necrosis; and (grades 5 to 8), cortical ne-
crosis. Tissue repair was also observed.
Urea measurement
Blood was drawn from the abdominal aorta under
ether anesthesia. Urea was measured in serum by the
urease method (Wiener Lab, Buenos Aires, Argentina).
VNTR detection in purified DNA from 7 μm sections of
paraffin-embedded kidneys.
Sections were cleansed with 100% xylene-etha-
nol (Carlo Erba, Italy) and digested with proteinase K
(100mM Tris-HCl, pH=8, 25mM EDTA, 0.5% SDS,
0.01% proteinase K) at 42ºC overnight. Lipoprotein
fractions were removed with phenol-chloroform-
isoamylic acid (Carlo Erba, Italy). Purified DNA was





(Tris-EDTA). The presence of the VNTR in
the promoter region of prostacyclin synthase gene was
analyzed with a semi-quantitative PCR technique.
DNA purity and yield were measured by spectropho-
tometry, and 200 ng of DNA were used for PCR. Re-
action volume was 25 μL. The PCR mixture contained
50 pmol of each primer, and a final concentration of
100 μM of each deoxyribonucleoside triphosphate, 10
mM Tris-HCl (pH 9.0), 50 mM KCl, 2 mM MgCl2,
and 1 unit of Taq DNA Polymerase (Promega Corpo-
ration, Madison, WI, USA). PCR was performed in a
Triothermoblock cycler (Biometra, Göttingen, Ger-
many) under the following conditions: 2 min at 95ºC,
for 35 cycles: 30 s at 95ºC, 60 s at 68ºC, 60 s at 72ºC,
and a final 10-min extension at 72ºC. A new pair of
primers homologous to the region flanking possible
VNTR in the promoter prostacyclin synthase rat gene
was designed with a computational primer design tool
(Primer3 Output). These primers amplified a 220-320
bp fragment. The oligonucleotide sequence was PGIS
F (5'-CGCCTCCCCAATCCCCTCTC-3') y PGIS R
(5'-CGGCTCAGCAGCAGCAGCAA-3'). PCR prod-
ucts were analyzed by electrophoresis on a 9% poly-
acrylamide gel in Tris-boric-EDTA 1X buffer, visual-
ized with ethidium bromide under ultraviolet light and
photographed. A 100 bp ladder (Promega Corporation)
was used as a size reference marker.
Histopathology
Both kidneys were removed and weighed; they
were fixed in buffered-formalin and embedded in par-
affin. Four to five μm sections were stained with he-
matoxylin and eosin to analyze histopathological al-
TABLE 1.
Choline-deficient diet composition (g/100 g)
Components Diet (%)
Soybean protein˙ 20.0








˙Grade II, Biochemical Corporation, U.S.; ˝Flora Dánica,
Buenos Aires, Argentina; ≈Mazola, Refinerías de Maíz,
Buenos Aires, Argentina; 4Celufil, non-nutritive bulk, Bio-
chemical Corporation, U.S.; 5Vitamin Diet Fortification Mix-
ture, Biochemical Corporation, U.S.; 6Salt Mixture, Wesson
Modification, Biochemical Corporation, U.S.; 7Biochemical
Corporation, U.S.
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Results
Initial body weight was 41.9 ± 1.0 g (n=10, mean ±
SEM). By the fifth day of feeding on the deficient diet
body weight was 57.3 ± 0.7 g (n=10). Final body weight
was 49.3 ± 2.1 g (n=6) in group 1 (those which died)
and 98.3 ± 4.0 g (n=4) in group 2 (surviving animals).
Both renal absolute weight and renal weight relative to
body weight, as well as serum urea concentrations (only
from group 2) are shown in Table 2. Urea levels in se-
rum were markedly high in the animals which survived
(group 2). Relative renal weight was significantly higher
in group 1 than in group 2 (P < 0.05, Student’s t test)
but absolute weights were similar in both groups (Table
2). Survival of rats in group 1 was 9.2 ± 0.2 days.
the overall distribution of allele frequencies was not sig-
nificantly different between animals which died due to
acute kidney failure and those which did not.
Research priorities in critical care are increasingly
focusing on long-term outcomes and prognosis for sur-
vivors of critical illness. Few studies have described the
long-term outcomes after acute renal failure. The long-
term survival after acute kidney injury is poor, variable
and range from 46 to 74%, 55 to 73%, 57 to 65% and 65
to 70% at 90 days, 6 months, 1 year and 5 years, respec-
tively. Further research is needed to explore the relation-
ship between survival, markers of morbidity and costs
after acute kidney injury (Bagshaw, 2006). The treatment
of critically ill patients with acute kidney injury has
changed dramatically over the last 30 years. As treatment
has increased in both sophistication and efficacy, so has
the severity of the condition (Bellomo, 2006). Despite
technical progress in the management of acute kidney
injury over the last 50 years, mortality rates seem to have
remained unchanged at around 50% (Ympa et al., 2005).
Acute kidney injury is present in 1 to 5 percent of pa-
tients at hospital admission and affects up to 20 percent
of patients in intensive care units (Needham, 2005). All
the data previously mentioned emphasizes the necessity
of new models of acute kidney injury.
The pathogenesis of the acute kidney injury due to
choline deficiency is controversial. As it has been men-
tioned above, the ischemic mechanism as well as a pri-
mary tubular damage has been proposed. Common ge-
netic polymorphisms are associated with changes in the
susceptibility to choline deficiency (Da Costa et al.,
2006). The rat is a useful experimental model for hu-
man acute kidney injury (Hammerman, 2000).
Several recent reports documented that VNTR poly-
morphisms located in the promoter region influence the
transcriptional activity, resulting in phenotypes with
functional differences (Tovar et al., 2003; Chevalier et
al., 2001). We described that the VNTR repeats upstream
of the insulin gene is a susceptibility locus for latent
autoimmune diabetes in adults (Cerrone et al., 2001).
Although the biological mechanism(s) behind these
polymorphisms are poorly understood, a defined length
for the regulatory region seems to be important for op-
timal gene transcription (Sabol et al., 1998). We con-
sidered that acute kidney injury due to choline defi-
ciency was an adequate experimental model to study its
pathophysiology.
As arachidonic acid derivatives are involved in the
regulation of vascular tonus and play an important role
in renal physiology and pathology, we hypothesized that
it would exist a possible relationship between this bio-
TABLE 2.
Absolute (g) and relative renal weight (g/100 g body
weight) and serum urea concentration (mg/dL) in rats
which developed acute renal failure and died (group 1)
and those which do not (and were sacrificed on day 21
of choline-deficient feeding; group 2).
Absolute Relative
n renal renal Urea
weight weight
Group 1 6 1.981 ± 0.156 4.004 ± 0.232 *
Group 2 4 1.910 ± 0.088 1.957 ± 0.145 99 ± 11
Results are expressed as mean ± SEM. *Serum urea could
not be determined in animals which died.
Rats in group 1 showed tubular (n=2) or cortical
(n=4) necrosis, while rats in group 2 showed reparative
changes (n=4).
The PCR-amplified product showed three differ-
ent weight bands in a 9% polyacrilamide gel, which run
between 220 and 320 bp standards. Both alleles were
paired in differently in each rat. We did not find differ-
ences in the molecular weight of the alleles between
groups 1 and 2. Control results were as expected.
Discussion
We investigated the possible association of a VNTR
polymorphism of the prostacyclin synthase gene with
the development of acute kidney injury. We found that
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logical phenomenon and the genetic structure of one of
the molecular candidates in terms of differential expres-
sion levels of some proteins in the animals which died
of acute renal failure and those which recovered.
There are many studies that described a relationship
between the number of tandem repetitions in the promoter
region of human prostacyclin synthase gene and differ-
ent pathologies. There is no evidence of the VNTR re-
gion in the promoter region in the prostacyclin synthase
rat gene, although there is a great homology between
human and rat. The coding region of the rat prostacyclin
synthase DNA copy shows 82.5% homology with the
human DNA copy (Miyata et al., 1994). Besides the
VNTR of prostacyclin synthase promoter gene was hard
to describe in human pathologies, and the high homol-
ogy that exists between rat and human, we could not use
the human primers described in the literature. Then, we
had to design the primers for the prostacyclin synthase
gene promoter region to be used in the rat, flanking the
possible VNTR sequence, and we then analysed a cohort
of rats by using PCR with primers which encompass the
VNTR region. Genotyping of 10 unrelated rats revealed
three PCR products that differed in size.
In conclusion, the existence of VNTR sequence was
established for the rat prostacyclin synthase gene pro-
moter region, but the reparation of the acute kidney in-
jury which occurs in some choline deficient rats is not
associated with differences in VNTR in the promoter
region of this gene.
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